- Home
- TIPT vs DNTH Comparison
TIPT vs DNTH Comparison
Compare TIPT & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIPT
- DNTH
- Stock Information
- Founded
- TIPT 2007
- DNTH 2015
- Country
- TIPT United States
- DNTH United States
- Employees
- TIPT N/A
- DNTH N/A
- Industry
- TIPT Property-Casualty Insurers
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- TIPT Finance
- DNTH Health Care
- Exchange
- TIPT Nasdaq
- DNTH Nasdaq
- Market Cap
- TIPT 803.7M
- DNTH 711.2M
- IPO Year
- TIPT 2007
- DNTH N/A
- Fundamental
- Price
- TIPT $21.05
- DNTH $23.62
- Analyst Decision
- TIPT
- DNTH Strong Buy
- Analyst Count
- TIPT 0
- DNTH 8
- Target Price
- TIPT N/A
- DNTH $46.43
- AVG Volume (30 Days)
- TIPT 68.4K
- DNTH 192.9K
- Earning Date
- TIPT 10-30-2024
- DNTH 11-07-2024
- Dividend Yield
- TIPT 2.32%
- DNTH N/A
- EPS Growth
- TIPT 357.81
- DNTH N/A
- EPS
- TIPT 0.97
- DNTH N/A
- Revenue
- TIPT $1,985,630,000.00
- DNTH $5,366,000.00
- Revenue This Year
- TIPT N/A
- DNTH $98.73
- Revenue Next Year
- TIPT N/A
- DNTH N/A
- P/E Ratio
- TIPT $22.02
- DNTH N/A
- Revenue Growth
- TIPT 27.40
- DNTH 51.41
- 52 Week Low
- TIPT $14.96
- DNTH $6.58
- 52 Week High
- TIPT $24.09
- DNTH $33.77
- Technical
- Relative Strength Index (RSI)
- TIPT 45.27
- DNTH 47.82
- Support Level
- TIPT $20.97
- DNTH $23.55
- Resistance Level
- TIPT $21.66
- DNTH $24.65
- Average True Range (ATR)
- TIPT 0.50
- DNTH 1.45
- MACD
- TIPT -0.17
- DNTH 0.14
- Stochastic Oscillator
- TIPT 17.57
- DNTH 38.79
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. Company has non reportable segment such as Tiptree Capital - Other and Corporate. It generates maximum revenue from the Insurance segment. The insurance segment provides specialty insurance, warranty products and related administration services; and the Mortgage segment originates, sell and service conventional, conforming agency and government-insured residential mortgage loans. Tiptree Capital - Other is the remainder of companies operations aggregated from mortgage and insurance. Corporate activities include holding company interest expense, corporate employee compensation and benefits, and other expenses.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.